NEW YORK, Jan. 21, 2026 (GLOBE NEWSWIRE) -- IO Biotech (IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results